Multi-omics analysis of NET+ TAN explains the immunosuppressive TME and prognosis value of malignant clinical characteristics in TNBC
2026 · Translational Oncology · 0 citations
https://doi.org/10.1016/j.tranon.2026.102692
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
0
Papers
0
Citations
Xiangxin Zheng is an academic researcher.
Click to start Chat